Nykredit A/S’s Haemonetics HAE Stock Holding History

Nykredit A/S’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186K	Buy	+2,485	New	+$160K	﹤0.01%	1068

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nykredit A/S's HAE Position: Q2 2026 in Review

Nykredit A/S opened a new position in Haemonetics (HAE) in Q2 2026: 2,485 shares worth $186K. The stake represents ﹤0.01% of the portfolio and ranks #1068 among its holdings.

244 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Nykredit A/S held 2,485 shares of Haemonetics worth $186K as of Q2 2026.
Haemonetics was a new Nykredit A/S position in Q2 2026.
Haemonetics made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1068 holding.
244 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.